SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Edison International is a renewable energy company, which operates through its subsidiaries. It supplies and distributes electric power, and also invests in energy services and technologies. The company was founded on July 4, 1886, and is headquartered in Rosemead, CA.

Edison International

Edison International is trending following a significant sell-off driven by investor concerns over potential wildfire liability linked to company infrastructure, with the community divided between those bracing for further downside from litigation and those viewing the dip as an attractive entry point for a resilient utility. Sentiment has been recently bolstered by news that the company has identified a homeless encampment near the fire's reported origin, leading some traders to speculate that liability claims may be mitigated.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as traders focus on the anticipated Phase 3 ORIGIN 3 eGFR analysis readout expected in the third quarter. Discussion highlights a divide between investors anticipating a positive catalyst or potential acquisition, and others expressing concern over competition and recent price volatility.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific (APAC). Its brands include Abercrombie and Hollister. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is experiencing heavy volatility and high trading volume following a strong earnings report that featured record revenue and raised full-year guidance, though traders remain divided over the extent to which one-time tariff refunds inflated the results. While some investors view the stock as an undervalued cash-generating machine with aggressive buybacks, a vocal group of traders continues to short the stock, labeling it a valuation trap that is overdue for a significant pullback.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending lower as investors digest escalating military tensions between the U.S. and Iran, which have driven oil prices higher and pushed Treasury yields to multi-year peaks. The market remains sensitive to concerns that these inflationary pressures could complicate the Federal Reserve's upcoming rate decision, fueling debates over the sustainability of current equity valuations.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E stock is trending following a decline triggered by Bank of America downgrading the company and slashing its price target after California wildfire legislation failed to pass. While some retail traders remain bullish and view the drop as an overreaction, others are concerned about unresolved wildfire liability risks and potential impacts on the company's long-term capital plans.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to rising oil prices fueled by escalating geopolitical tensions in the Middle East, particularly following recent U.S. military strikes near the Strait of Hormuz. Community discussion is characterized by intense debate between traders banking on further price increases and those speculating that the rally is a manipulation or unsustainable.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing heightened volatility and mixed sentiment as traders balance concerns over valuation and guidance with anticipation for the upcoming earnings report. The conversation reflects a divide between those concerned about competitive pressure in the AI connectivity market and those who view the stock as undervalued, betting that strong AI-driven revenue will catalyze a rebound.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is trending as investors monitor ongoing geopolitical instability in the Strait of Hormuz, which continues to drive volatility in oil prices and fuel inflation concerns. While some traders are capitalizing on sector strength and potential breakout patterns, others remain cautious regarding long-term supply disruptions and the sustainability of recent energy sector performance.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

A hawkish Federal Reserve message from Kevin Warsh pushed Treasury yields and rate-hike expectations higher, pressuring gold and triggering a sharp pullback in gold miners. Traders are divided between those expecting further correction after an overbought rally and longer-term bulls who view debt, inflation, Treasury intervention, and potential rate cuts as supportive for precious metals.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

A strong fiscal Q4 beat and raised outlook have focused attention on Seagates AI- and cloud-driven mass-storage demand, with HAMR technology and tight HDD supply supporting expectations for continued margin growth. Traders remain divided, with bulls viewing the results as evidence of a durable storage upcycle while bears point to elevated valuation, sector-wide deleveraging, and cyclical risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?

Key PointsCOO Cheryl Gault sold 10,000 shares on June 30, 2026, for a transaction value of ~$416,000, based on a weighted average price of $41.58 per share...

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

Rapport Therapeutics, Inc. (RAPP) delivered earnings and revenue surprises of +24.66% and 0.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday

Rapport Therapeutics (NASDAQ:RAPP) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Receives Consensus Rating of "Buy" from Brokerages

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) has been assigned a consensus rating of "Buy" from the ten brokerages that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have issued a buy rating and two have issued a s...

Rapport Insider Sells $17.2 Million as Stock Surges 230% in a Year and Phase 3 Trials Near

Key PointsA major owner of Rapport Therapeutics reported selling 426,005 shares for a total value of approximately $17.18 million on April 17, 2026...

BTIG Research Reaffirms "Buy" Rating for Rapport Therapeutics (NASDAQ:RAPP)

BTIG Research restated a "buy" rating and issued a $53.00 target price on shares of Rapport Therapeutics in a research note on Wednesday...

Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Insider Sells 20,225 Shares of Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 20,225 shares of Rapport Therapeutics stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $39.99, for a total value of $808,797.75. Following the transaction, the...

Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Major Shareholder Sells 426,005 Shares of Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) major shareholder Rock Ventures L.P. Third sold 426,005 shares of Rapport Therapeutics stock in a transaction dated Friday, April 17th. The...

Krishnaswamy Yeleswaram Sells 20,225 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 20,225 shares of the company's stock in a transaction on Friday, April 17th. The stock was sold at an average price of $39.99, for a total transaction of $808,797.75. Following the completion of the...

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.2% - Here's What Happened

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.2% - Time to Sell...

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

RAPP Rapport Therapeutics Inc

Fundamentals

Latest RAPP News